Prevalencia por áreas sanitarias de enfermedad renal crónica en la población diabética de Extremadura durante los años 2012, 2013 y 2014. Un estudio observacional Leandro Fernández-Fernández; Javier Goujat-Salas; Carmen Ceballos-Malagón; Manuel Tejero-Mas; Francisco Luis Pérez-Caballero; Francisco Buitrago-Ramírez;

Healthcare models, quality indicators and quality of care in the management of patients with chronic kidney disease in Spain: results from the CARABELA-CKD initiative Mercedes Salgueira; Pedro Ruiz; Jesús Ignacio Diago; Manuel Pérez Maraver;

Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;